Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medicine,
Division of Hematology-Oncology,
Department of Medicine, Division of Hematology-Oncology
Scott G. Kitchen has not added Biography.
If you are Scott G. Kitchen and would like to personalize this page please email our Author Liaison for assistance.
Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor.
Blood Jan, 2002 | Pubmed ID: 11756173
The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.
AIDS research and human retroviruses Jan, 2004 | Pubmed ID: 15000703
CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.
Proceedings of the National Academy of Sciences of the United States of America Jun, 2004 | Pubmed ID: 15173593
The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2005 | Pubmed ID: 15731353
Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development.
Current HIV research Oct, 2005 | Pubmed ID: 16250884
Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research Nov, 2005 | Pubmed ID: 16318584
T lineage differentiation from human embryonic stem cells.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2006 | Pubmed ID: 16844782
Enfuvirtide antiretroviral therapy in HIV-1 infection.
Therapeutics and clinical risk management Apr, 2008 | Pubmed ID: 18728846
Generation of T lineage cells from human embryonic stem cells in a feeder free system.
Stem cells (Dayton, Ohio) Jan, 2009 | Pubmed ID: 18974209
Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.
PloS one , 2009 | Pubmed ID: 19997617
Stem cell-based approaches to treating HIV infection.
Current opinion in HIV and AIDS Jan, 2011 | Pubmed ID: 21242896
Stem cell-based anti-HIV gene therapy.
Virology Mar, 2011 | Pubmed ID: 21247612
In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1.
The open medical informatics journal , 2010 | Pubmed ID: 21603285
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication.
PloS one , 2012 | Pubmed ID: 22427811
In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.
PLoS pathogens , 2012 | Pubmed ID: 22511873
David Geffen School of Medicine at UCLA
UCLA AIDS Institute
Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA
Dimitrios N. Vatakis1,2,3,
Gregory C. Bristol1,2,
Sohn G. Kim1,2,
Bernard Levin1,2,
Wei Liu4,
Caius G. Radu4,
Scott G. Kitchen1,2,3,
Jerome A. Zack1,2,5
1Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA,
2, UCLA AIDS Institute,
3, Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA,
4Department of Medical and Molecular Pharmacology, David Geffen School of Medicine at UCLA,
5Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved